Abstract
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild type colorectal cancer patients receiving irinotecan/cetuximab
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have